Home

Sandra M Gurrola

CIK 1618457 · Sr. VP of Finance · last filed 2025-07-07

Sandra M Gurrola is a Sr. VP of Finance who has filed 46 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for ERNA, was dated Jul 7, 2025. Current disclosed insider exposure totals $6.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.7K

Companies

3

Total Filings

46

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ERNA Sr. VP of Finance 4 $3.61 $14 $0 5 2025-07-07
BTX Vice President of Finance 848 $7.87 $6.7K $0 4 2022-06-23
Ernexa Therapeutics Inc. (NTN) Delisted Former SVP of Finance 21,617 $2.70 $58.4K $0 35 2021-03-26

Recent Filings

46 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-07-07 ERNA Exer (M) +30 $0 EDGAR
2025-02-10 ERNA Grant (A) — $0 EDGAR
2024-06-25 ERNA Mixed +257 -$349 EDGAR
2024-04-29 ERNA Grant (A) — $0 EDGAR
2023-06-23 ERNA Mixed +259 -$444 EDGAR
2022-06-23 BTX Mixed +5,164 -$1.7K EDGAR
2022-03-17 BTX Grant (A) — $0 EDGAR
2022-03-15 BTX Grant (A) — $0 EDGAR
2021-06-22 BTX Grant (A) — $0 EDGAR
2021-03-26 Ernexa Therapeutics Inc. (NTN) Delisted Tax (F) −6,094 -$16.3K EDGAR
Showing 1–10 of 46
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.